Table 2.
Characteristics of patients with mucinous ovarian cancer with a recurrence free interval > 6 months compared to other histological subtypes at the time of the diagnosis of recurrence.
| Mucinous | Other histotypes | p | |
| Number of patients | 20 | 388 | |
| Age (years) | 20 | 380 | |
| Mean (± s.d.) | 57.6 ± 12.8 | 59.8 ± 10.8 | n.s.* |
| Median | 58 | 60.5 | |
| Range | 28–78 | 33–97 | |
| PS Ecog | 20 | 360 | |
| 0 | 45.0% | 62.8% | 0.0241** |
| 1 | 40.0% | 33.9% | |
| 2 | 15.0% | 3.3% | |
| 3 | . | . | . |
| Recurrence free interval (N) | 17 | 378 | |
| 6–12 months | 58.8% | 38.9% | n.s.** |
| > 12 months | 41.2% | 61.1% | |
| median (range) – months: | 10.6 (5–141) | 15.3 (5–160) | n.s.**** |
| Number of disease sites | 20 | 335 | |
| 1 | 25.0% | 44.8% | n.s.** |
| > 1 | 75.0% | 55.2% | |
| Surgery | 19 | 375 | |
| Yes | 26.3% | 20.5% | n.s.*** |
| No | 73.7% | 79.5% | |
| Result of cytoreductive surgery | 5 | 64 | |
| No residual | . | 50.0% | 0.0308*** |
| Residual desease | 100.0% | 50.0% | |
| Ca 125 | 14 | 247 | n.s.** |
| Normal: ≤ 35 | 14.3% | 12.1% | |
| > 35 U/ml | 85.7% | 87.9% | |
* t-test; ** χ2 Mantel-Haenszel; *** χ2; ****Wilcoxon